# ๐Ÿ”ฌ Other Cystic Kidney Diseases ### โšก Emergency Recognition Protocol 1 **Neonatal ARPKD:** Oligohydramnios + enlarged kidneys โ†’ Immediate respiratory support 2 **Cholangitis:** Fever + RUQ pain in ARPKD โ†’ Urgent antibiotics, biliary drainage 3 **Portal Hypertension:** GI bleeding + splenomegaly โ†’ Endoscopic evaluation 4 **Progressive CKD:** Unexplained kidney failure in child โ†’ Genetic evaluation ### ๐Ÿงฌ Spectrum of Cystic Kidney Diseases Beyond ADPKD - Understanding rare hereditary and acquired cystic diseases #### ๐Ÿงฌ Autosomal Recessive ARPKD, Nephronophthisis - Early onset, severe phenotype #### ๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Autosomal Dominant MCKD - Adult onset, variable progression #### ๐Ÿ”ง Developmental Medullary sponge kidney - Congenital collecting duct abnormality ### ๐Ÿ‘ถ Autosomal Recessive PKD (ARPKD) - **Incidence:** 1:20,000-50,000 live births - **Genetics:** PKHD1 gene mutations (chromosome 6p12) - **Perinatal Form:** Enlarged echogenic kidneys, oligohydramnios - **Pulmonary Hypoplasia:** High mortality from respiratory complications - **Congenital Hepatic Fibrosis:** Portal hypertension, cholangitis risk - **Variable Presentation:** Perinatal, infantile, childhood onset ### ๐Ÿ”ฌ ARPKD Management - **Respiratory Support:** Ventilatory support for neonatal patients - **Conservative CKD Care:** Growth, bone health, anemia management - **Hepatic Monitoring:** Portal pressure, varices screening - **Genetic Counseling:** 25% recurrence risk for siblings - **Multidisciplinary Team:** Pediatric nephrology, hepatology - **Transplant Planning:** Combined liver-kidney in severe cases ### ๐Ÿงฌ Nephronophthisis-Medullary Cystic Disease Complex #### ๐Ÿ‘ถ Nephronophthisis (NPH) - **Inheritance:** Autosomal recessive - **Age of Onset:** Juvenile - median ESRD age 13 years - **Most Common:** Inherited cause of ESRD in children - **Extrarenal:** Retinal dystrophy, liver fibrosis - **Genetics:** \>20 genes identified (NPHP1 most common) - **Phenotype:** Small kidneys, concentrating defect #### ๐Ÿ‘จโ€โš•๏ธ ADTKD (formerly Medullary Cystic Disease) - **Current Name:** Autosomal Dominant Tubulointerstitial Kidney Disease (ADTKD) - **Inheritance:** Autosomal dominant - **Age of Onset:** Adult - ESRD around age 50 - **Association:** Hyperuricemia and gout common - **Genetics:** UMOD, REN gene mutations - **MCKD1:** Chromosome 1q21, unknown gene - **MCKD2:** Uromodulin (UMOD) mutations #### ๐Ÿ” Common Features of NPH-MCKD Complex **Tubular basement membrane disintegration** **Medullary cysts at corticomedullary junction** **Concentrating defect with polyuria** ### ๐Ÿงฎ Cystic Disease Differential Diagnosis Tool Age of Onset: Family History: Kidney Size: Associated Features: Clinical Course: Most Likely Diagnosis Autosomal Dominant PKD Based on clinical presentation pattern ### ๐Ÿบ Medullary Sponge Kidney - **Prevalence:** ~1:5,000 population - **Pathology:** Cystic dilatation of collecting ducts - **Bilateral:** 70% of cases involve both kidneys - **Age of Presentation:** Usually third decade - **Stone Association:** High risk for nephrolithiasis - **Imaging:** "Bouquet of flowers" or "paint brush" pattern ### โš ๏ธ MSK Complications - **Nephrolithiasis:** Calcium phosphate stones common - **Urinary Tract Infections:** Recurrent UTIs from stasis - **Hematuria:** Gross or microscopic bleeding - **Renal Tubular Acidosis:** Distal (Type 1) RTA - **Hypercalciuria:** Often present, increases stone risk - **Hyposthenuria:** Concentrating defect ### ๐Ÿฅ Comprehensive Management Approach 1 **Genetic Counseling:** Family risk assessment, inheritance patterns, reproductive planning 2 **Supportive Care:** CKD management, growth support, bone health, anemia treatment 3 **Complication Prevention:** Stone prevention, infection treatment, BP control 4 **Transplant Planning:** Pre-emptive evaluation, living donor assessment 5 **Monitoring Protocol:** Regular eGFR, imaging, extrarenal manifestations ### ๐Ÿงฌ Genetic Testing in Cystic Diseases #### Indications for Testing - Uncertain diagnosis with atypical features - Early-onset kidney disease - Family planning and genetic counseling - No family history in suspected hereditary disease - Extrarenal manifestations present #### Available Tests - Single gene sequencing (PKHD1, NPHP genes) - Multi-gene panels for cystic diseases - Whole exome sequencing for complex cases - Chromosomal microarray for syndromic features - Prenatal diagnosis when indicated #### Key Genes in Cystic Disease **ARPKD:** PKHD1 **NPH:** NPHP1-20 **MCKD:** UMOD, REN **Rare forms:** HNF1B, DZIP1L ### ๐Ÿ“‹ Cystic Disease Management Comparison [TABLE] ### ๐ŸŽฏ Key Learning Points #### Early Recognition Age of onset and family history are crucial clues for differential diagnosis of inherited cystic diseases. #### Multisystem Disease Most cystic diseases involve multiple organ systems requiring comprehensive evaluation and management. #### Genetic Counseling Inheritance patterns affect family planning decisions and screening recommendations for at-risk relatives. #### Supportive Care Focus Treatment remains largely supportive with emphasis on complication prevention and CKD progression management. --- [Website version](https://urinenephrology.org/2025_UDPA_Lectures_Live/kidney-cysts-masses/cystic-diseases/other-cystic-diseases.html) ยท Markdown synchronized October 3, 2026.